VX-11e

CAT: 0804-HY-14178-01Size: 5 mgDry Ice: NoHazardous: No
CAT#:0804-HY-14178-01Size:5 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
VX-11e is a potent, selective, and orally bioavailable inhibitor of ERK with Ki < 2 nM.
CAS Number
[896720-20-0]
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
ERK
Type
Reference compound
Related Pathways
MAPK/ERK Pathway; Stem Cell/Wnt
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/VX-11e.html
Purity
98.94
Solubility
DMSO : ≥ 100 mg/mL
Smiles
FC1=CC(Cl)=C(NC2=NC(C3=CNC(C(N[C@H](CO)C4=CC=CC(Cl)=C4)=O)=C3)=C(C)C=N2)C=C1
Molecular Formula
C24H20Cl2FN5O2
Molecular Weight
500.35
Precautions
H302, H315, H319, H335
References & Citations
[1]Aronov, Alex M., et al. Structure-Guided Design of Potent and Selective Pyrimidylpyrrole Inhibitors of Extracellular Signal-Regulated Kinase (ERK) Using Conformational Control. Journal of Medicinal Chemistry (2009), 52 (20), 6362-6368.|[2]Krepler C, et al. Personalized Preclinical Trials in BRAF Inhibitor-Resistant Patient-Derived Xenograft Models Identify Second-Line Combination Therapies. Clin Cancer Res. 2016 Apr 1;22 (7) :1592-602.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
ERK2

Related Products

CatalogName
HY-10401-01VX-702
HY-118917VX-148
HY-119161VX-759
HY-19939S-01VX-984
HY-16521VX-166
HY-139346-01VX-150
HY-101735-01(9Z,11E) -Prodlure
HY-CE00051A(11E) -Octadecenoyl-CoA
HY-10401R-01VX-702 (Standard)
HY-19939S2(R) -VX-984

Alternative Products

CatalogName
C18025VX-11e
468786-01VX 11e
T78143-01(R) -VX-11e
MBS385719-01TCS ERK 11e (VX-11e)
MBS5819812(R)-VX-11e
A12505-5TCS ERK 11e (VX-11e) 5mg
A12505-25TCS ERK 11e (VX-11e) 25mg
A12505-10TCS ERK 11e (VX-11e) 10mg
A12505-2TCS ERK 11e (VX-11e) 2mg
A12505-50TCS ERK 11e (VX-11e) 50mg

Popular Products